Advertisement

Model Predicts Persistent Opioid Use After Total Knee Replacement

0

Reduced model with 10 predictors identifies persistent high-dose opioid use with high discrimination

Cannabis Dispensaries Negatively Linked to Opioid-Related Death

0

Particularly strong negative association seen for dispensary count with deaths caused by synthetic opioids other than methadone

HealthDay Reports: Record-High Numbers of New COVID-19 Cases Seen in 14 States

United States Sees Continued Drop in New COVID-19 Cases

0

Current decline in infections most pronounced in the Midwest

Johnson & Johnson's One-Dose COVID Vaccine Promising in Early Trial

J&J Submits EUA Request for COVID-19 Vaccine

0

FDA committee will hold public meeting to discuss the EUA request on Feb. 26

Lo que usted debe saber sobre las vacunas contra la COVID

High Efficacy Reported for Sputnik V COVID-19 Vaccine

0

Interim analysis of data from phase 3 trial shows 91.6 percent efficacy at 21 days after the first dose of the vaccine

HealthDay Reports: Lab Experiments Show How Masks Could Protect Against COVID-19

Companies Developing Vaccines Against New Coronavirus Variants

0

GlaxoSmithKline and CureVac to create vaccines that use messenger RNA to combat the virus

HealthDay Reports: Why Are Blacks

Racial Disparities Seen in Excess Mortality Early in Pandemic

0

Adjusted excess all-cause mortality was 6.8 per 10,000 for Blacks and 1.5 per 10,000 for Whites, with considerable variation across states

B 2/4 - Major Medical Groups Urge Americans to Get COVID Vaccine

First Federal COVID-19 Vaccination Sites to Open in California

0

One center will be housed in the Oakland Coliseum, another on the campus of California State University, Los Angeles

Sildenafil

McKinsey to Pay $573 Million Over Role in Opioid Crisis

0

Most of the money would be distributed to states in less than a year and be used to combat the opioid overdose epidemic

ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL

Oncology Clinical Trials Decline During Pandemic

0

Decline in trial launches could have long-term negative impact, authors say